ד"ר יקיר משה

• רפואה פנימית – בי"ח רמב"ם
• המטולוגיה – בי"ח איכילוב

​7 פרסומים והצגות בכנסים מדעיים:

• Berger T, Rozovski U, Moshe Y, Yaari S, Frisch A, Hellmann I, Apel A, Aviram A, Koren-Michowitz M, Yeshurun M, Ram R, Raanani P, Ofran Y, Wolach O. Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study. Ann Hematol. (2019)
• Ram R, Scheid C, Amit O, Chemnitz JM, Moshe Y, Hallek M, Wolf D, Avivi I, Holtick U. Sequential therapy for patients with primary refractory acute myeloid leukemia - historical prospective analysis of the German and Israeli experience. Haematologica. (2019)
• Moshe Y, Bentur OS, Lishner M, Avivi I. The management of hodgkin lymphomas in pregnancies. Eur J Haematol.  Nov;99(5):385-391 (2017).
• Moshe Y, Bar-On O, Ganoth D, Hershko A. Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases. J Biol Chem. 286(19):16647-57. (2011).
• Braunstein I, Miniowitz S, Moshe Y, Hershko A. Inhibitory factors associated with anaphase-promoting complex/cylosome in mitotic checkpoint. Proc Natl Acad Sci U S A. 104(12):4870-4875. (2007)
• Eytan E, Moshe Y, Braunstein I & Hershko A. Roles of the anaphase promoting complex/Cyclosome and it's co-activator Cdc20 in functional substrate binding. Proc. Natl. Acad. Sci. USA, 103(7):2081-6 (2006).
• Moshe, Y., Boulaire, J., Pagano, M. & Hershko, A. Role of Polo-like kinase in the degradation of Emi1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl. Acad. Sci. USA 101, 7937–7942 (2004).

• ​לוקמיה מילואידית חריפה
• לוקמיה לימפואידית חריפה
• לוקמיה פרומיילוציטית חריפה
• תסמונת מיילודיספלסטית